Antidote’s learnings from over 1,900 depression patients [whitepaper]

Depression, also known as clinical depression, Major Depressive Disorder, or MDD, is estimated to impact one out of six adults at some point in their lifetime, making it one of the most common mental disorders in the United States. It is estimated that the cost of depression totals $100 billion annually. While there are treatments available, finding the optimal one can place a significant burden on the patient — this is why depression studies are essential for discovering new options.

To gain more insight into patient motivation and successful recruitment for depression studies, Antidote tapped into our database to analyze information from over 1,900 individuals who have searched for a depression trial. Our learnings include insights into demographics, medication use, patient-centric trial design, and more. To get all the details, click the button below.